There was no significant correlation in the frail group. Conclusion: In the studied sample, higher insulin, HbA1c, and IR were associated with better cognitive functions in prefrail elderly, and were not associated with worse cognition in frail elderly.
Medicine, Ain Shams University. Each subject gave informed consent and patient anonymity was preserved. All subjects underwent comprehensive geriatric assessment, including Arabic version of Geriatric Depression Scale 15-items (GDS-15), results ≥ 5 were considered positive for depression [20] .
Assessment of Frailty
Frailty was defined according to the construct previously validated by Fried et al. [21] in the Cardiovascular Health Study. All five components from the original phenotype were retained; however, the metrics used to characterize the frailty criteria were slightly different and defined as follows [9] :
Shrinking: Recent and unintentional weight loss of ≥3 kilograms (Kg) in the prior year was identified and body mass index was calculated. Participants who answered "yes" for weight loss or had a body mass index < 21 kg/m 2 were considered to be frail for this component. Poor endurance and energy: As indicated by self-report of exhaustion, identified by two questions from the Center for Epidemiological Studies-Depression scale [22] : "I felt that everything I did was an effort" and "I could not get going." Participants were asked: "How often, in the last week, did you feel this way?" 0 = rarely or none of the time; 1 = some or a little of the time; 2 = a moderate amount of the time; or 3 = most of the time. Participants answering "2" or "3" to either of these questions were considered as frail for this component.
Slowness: Meets criteria for frailty if time to walk 6 meters was > 8 seconds for height ≤ 173 centimeters (cm) or > 7 seconds for height > 173 cm in males, and > 8 seconds for height ≤ 159 cm or > 7 seconds for height > 159 cm in females.
Weakness: Participants answering "yes" to the following question were categorized as frail for this component: "do you have difficulty rising from a chair?" Low physical activity: A single response was used to estimate physical activity. Individuals who denied doing daily leisure activities such as walking or gardening and/or denied doing some sport activity per week were categorized as physically inactive. Those who reported doing them were considered to be physically active.
As proposed by Fried and colleagues, the participants were considered to be "frail" if they had three or more frailty components among the five criteria; they were considered "prefrail" or "intermediate" if they fulfilled one or two frailty criteria, and "nonfrail" if none.
Cognitive Tests
Apart from MMSE test [19] , a battery of cognitive tests was administered including Verbal Fluency (VF) test in which subjects had to enumerate as many animals (four legged) as possible within one minute [23] ; Digit Span Forward (DSF) test [24] , and Digit Span Backward (DSB) test [24] , these tests were done through repetition of numbers in order (DSF) and in reverse order (DSB); Block Design (BD) test that requires the subject to use three-dimensional blocks to construct a model from a two-dimensional stimulus card [24] , performance is timed. Although bonus points are awarded for speed, the score is either all or none, that is, a score is awarded only if the model is correctly produced within the prescribed time limit; and contrast Programming (CP) test [25] , in which the examiner will randomly hold up either one or two fingers; the patient is instructed to do the opposite, i.e., to hold up two fingers when the examiner holds up one or vice-versa. Ten trials were done; patient is scored according to the number of true trials.
Activities of Daily Living and Instrumental Activities of Daily Livings
Activities of daily living (ADL) [26] and Instrumental Activities of Daily Livings (IADL) [27] were used to assess the ability of the patient to complete basic and advanced self care tasks consecutively.
Laboratory Investigations
Laboratory investigations included measurement of; serum insulin, CRP, HbA1c, FBS, and IGF-1 levels. They were measured as follows: Samples: 5 mL of whole blood was drawn from each participant after 8 hours fasting, and were divided into 2 tubes: 1 mL in Ethylene diamine tetraacetic acid anti-coagulated tube for HbA1c assay, and 4 mL allowed to clot in a plain tube. The resulting serum was used for immediate assay of FBS and quantitative CRP, and the remaining serum was frozen to −70˚C till assay of insulin and IGF-1.
Laboratory Analysis
HbA1c was assayed by ion-exchange chromatographic separation and colorimetric detection kit (Biosystems, SA, Barcelona, Spain). FBS was assayed on Synchron CX-5 autoanalyzer using manufacturer's reagents (Beckman Instruments Inc., Fullerton, USA). Quantitation of CRP was performed by immunoturbidimetric assay using Biosystems CRP kit. Insulin and IGF-1 were measured by enzyme-linked immunosorbent assay, using kits supplied by DRG International Inc. (New Jersey, USA). The former is based on sandwich principle, where capture antibodies coated on microtiter wells bind insulin, followed by anti-insulin tracer antibody-conjugate that reacts with its substrate giving a color directly proportional to insulin concentration; whereas the latter is based on competitive principle, where IGF-1 in the sample competes with biotinylated IGF-1 for microtiter-fixed capture antibodies; followed by addition of streptavidin-horseradish peroxidase complex to react with a specific substrate giving a color inversely proportional to the IGF-1 in the sample.
Finally, insulin resistance was assessed using Homeostasis Model of Assessment-Insulin Resistance (HOMA-IR) approach, HOMA-IR was calculated as follows FBS (mg/dl)) × fasting insulin (μIU/mL)/405 [28] . HOMA-IR is a useful model for assessing IR by a single measurement of FBS and fasting insulin levels [28] . HOMA-IR has been validated using the euglycemic hyperinsulinemic clamp method [29] [30], which is an expensive and invasive gold standard method [31] .
Statistical Analysis
Statistical Package for the Social Sciences (SPSS) version 16 (SPSS Inc., Chicago, IL, USA) was used in data analysis. Qualitative data were expressed in the form of number and frequency. Quantitative data were expressed in the form of mean +/− SD. Chi-square test was used to compare between groups. Quantitative data were tested for normal distribution using one sample Kolmogorov Smirnov test; non-parametric data were converted to parametric data by log transformation. Analysis of variance (ANOVA) followed by Least Significant Difference was used to compare between groups and Pearson correlation coefficient was used for correlation.
Results
The mean age (± SD) of the studied group was 68.2 ± 6.95 years. Their demographic characteristics are shown [ Table 1 ]. A significant difference was found between frail, pre-frail and controls (non-frail) regarding the following variables; mean age and hypertension distribution (P = 0.01 for both); HOMA-IR and IGF-1levels (P = 0.003 for both); CRP levels, HbA1c levels and FBS levels (P < 0.001 for all); CP (P = 0.006), DSF (P = 0.007), DSB (P = 0.042) and VF (P = 0.015) [ Table 1 ]. By post Hoc analysis, the only significant data were as follows: frail elderly were significantly older than non-frail elderly (P = 0.002). They had significantly worse performance than both non-frail (P = 0.003) and pre-frail elderly (P = 0.028) in CP test. As regards DSF, DSB and VF tests; frail elderly performed significantly worse than non-frail elderly (P = 0.002, 0.012 and 0.004 respectively). IR as assessed by HOMA-IR was significantly higher in frail and pre-frail than non-frail elderly (P < 0.001, and 0.046 respectively). In addition, frail elderly had significantly lower IGF-1 (P < 0.001) and higher CRP (P < 0.001) and HbA1c (P < 0.001) than non-frail elderly. Furthermore, pre-frail elderly had higher CRP and HbA1c than non-frail elderly (P < 0.001 for both). Frail elderly had significantly higher insulin than non-frail elderly (P = 0.043). FBS was significantly higher in frail and pre-frail than non-frail elderly (P < 0.001 for both).
Regarding the physical activity, there was significant difference between the 3 groups in ADL and IADL scores [ Table 1 ]. By post hoc analysis, frail elderly had significantly worse scores than both prefrail and the control groups in ADL (P < 0.001 for both) and in IADL (P < 0.001 for both). The prefrail had significantly worse score than the control group in ADL and IADL (P = 0.05 and <0.001 consecutively).
Using correlation tests, after adjustment for age, gender, and education, CRP in the control group showed a negative correlation with CP, DSB and MMSE (P = 0.01, 0.001 and 0.004 respectively). No significant correlations were observed between CRP or IGF-1 and cognition in the frailty group except for a negative one regarding DSB test scores with CRP (P = 0.045) and a positive one for the same test with IGF-1 (P = 0.002), in the pre-frail group [ Table 2] .
As regards insulin level, HOMA-IR, and HbA1c level, none of them did show a significant correlation with cognitive test results in the frail group. Regarding the pre-frail ones, HOMA-IR and insulin level were positively correlated with DSB (P = 0.012 and 0.045 respectively), while HbA1c level was positively correlated with CP test results (P = 0.01). On the other hand, controls showed a positive correlation between HOMA-IR and the following cognitive tests CP (P = 0.009), DSB (P = 0.03), and MMSE (P = 0.002), while their insulin level was positively correlated with DSB and MMSE (P = 0.005 and <0.001 respectively) and finally HbA1c level was positively correlated with DSF (P = 0.008) [ Table 3 ].
Discussion
After adjustment for age, gender and education, current data revealed that insulin and HOMA-IR were positively correlated with some cognitive tests in non frail subjects, along with HOMA-IR < 2.5 (a cut off for IR) [32] , and combined HbA1c < 6.5 and FBS < 126 mg/dl, as a combined cut offs for diagnosis of DM in asymptomatic patients [33] . Therefore, IR is associated with better cognition in non frail subjects in the presence of these laboratory parameters.
This is in accordance with Kaplan et al. [34] who conducted a study upon 10 males and 10 females free-living subjects aged 60 -82 y in whom evidence of DM (FBS ≥ 126 mg/dl) or cognitive decline were used as exclusion criteria. They found poor baseline verbal declarative memory (immediate and 20-min delayed paragraph recall and word list recall) and visuomotor task performance were predicted by low IR.
Furthermore, Euser et al. [35] found that elevations in FBS levels are not associated with impaired cognitive function or with an accelerated rate of cognitive decline in subjects without a history of diabetes. In addition, there was no clear relationship between HOMA-IR index and cognitive function and decline in subjects without a history of diabetes. They suggested that cognitive decline is enhanced strongly once a subject is diabetic. However, there is no decline in cognition with lesser degrees of dysglycemia. Absence of positive association between FBS and HOMA-IR and cognition in Euser et al. [35] study could be attributed in part for excluding diabetic patients only by history.
Our control subjects possess the lowest levels of CRP; which impair the insulin signaling pathway [15] , and the highest levels of IGF-1 that play a key mediator of the ability of physical activity to enhance neurogenesis [16] . Therefore, this control group was suspected to have the best neurogenesis and insulin signaling.
In the prefrail subjects, the current results revealed that insulin, HOMA-IR and HbA1c were positively correlated with some cognitive tests, along with some cases that have HOMA-IR ≥ 2.5, HbA1c ≥ 6.5 and FBS ≥ 126 mg/dl.
There was a positive association between hyperinsulinemia and hyperglycemia, along with the presence of IR and diabetes, and better cognition in prefrail subjects. This could be explained by the benefit exerted by higher peripheral insulin and peripheral hyperglycemia to compensate for lower brain insulin signaling as more energy (in form of glucose) will be diverted to the insulin independent tissues (as brain and red blood cells) and less to tissues which is insulin dependent (as skeletal muscles and liver) [36] .
This impacts cognition because insulin receptors are present in many areas of the brain. Insulin and insulin receptors in the brain are associated with neuronal development [1] - [3] and have impact upon cognitive functions [7] . This finding is supported by Burns and colleagues in a cohort of early AD, [12] which is known to have impaired CNS insulin signaling [11] . They found that higher peripheral insulin and glucose levels, in their cohort sample after follow up for 2 years, were accompanied by lower rates of whole and regional brain atrophy [12] . This is further supported by 2 further studies suggesting that subjects with type II DM and AD had lower decline in cognition than non-diabetic subjects with AD [37] [38] . Furthermore, intranasal insulin preserved general cognition in mild to moderate AD patients [39] . This refers to the differential relation of insulin and cognition which could help to explain our results.
One of the important factors that decrease brain insulin sensitivity and impair insulin signaling is the increased expression of inflammatory markers within the brain [40] , which is the case in frailty and to a lesser extent in pre-frailty. The heightened inflammatory state is observed by the increased levels of molecular and cellular inflammatory markers compared with that observed in non-frail individuals [13] .
However, in the frail subjects, the current study found that insulin, HOMA-IR and HbA1c were not positively correlated with cognitive tests, along with some cases that had HOMA-IR ≥ 2.5, HbA1c ≥ 6.5 and FBS ≥ 126 mg/dl. This means that insulin, HOMA-IR and HbA1c might have no positive association with cognition in frail elderly in spite of the presence of hyperinsulinemia and the suspected decrease in the brain insulin signaling.
As regards our frail subjects, they are mostly in the zone of not getting benefit from high insulin, HbA1c and IR levels due to decreased physical activity. Our pre-frail subjects showed a statistically significant better performance in ADL than frail subject. Decreased physical activity, as it is the case with frail elderly, has effect on sustaining the vascular health of the brain. Experimental studies have found that physical activity enhances cerebral blood flow, increases cerebral capillary density, and decreases radical oxidative protein deposits [41] . In animal models, exercise enhances concentration of brain-derived neurotrophic factors, in addition to other growth factors, stimulates neurogenesis, enhances resistance to brain insults, and stimulates gene expression that could benefit brain plasticity processes [42] . The suspected decrease of the brain protection in frail subjects could underlie the absence of positive association between cognitive tests and HbA1c and HOMA-IR, despite the presence of hyperinsulinemia and hyperglycemia along with the suspected impaired insulin signaling in the frail subjects.
Conclusion
In our sample, frail elderly had the worst performance in some cognitive tests. Furthermore, higher insulin, HbA1c, and IR were associated with better cognitive functions in pre-frail elderly, and were not associated with worse cognition in frail elderly. Therefore, insulin may have a differential relation to cognitive functions. The conclusion needs further study before generalizing the sentence as a fact.
Limitations
The limitations of the current study are the relatively small sample size and not excluding diabetic cases. However, presence of positive correlation between HOMA-IR, insulin, HbA1c and cognitive tests in pre-frail, along with the absence of negative correlation in frail elderly gives further support to our idea that insulin might be associated with better cognition in pre-frail and frail elderly, as it is known that DM impairs cognitive functions [43] .
Recommendations
Future studies could test the causative association between hyperglycemia and hyperinsulinemia and cognition in frail and prefrail subjects. In addition, the impact of intranasal insulin therapy upon cognition in pre-frail and frail subjects might be tested.
